Health Condition 1: C50- Malignant neoplasm of breast Health Condition 2: C34- Malignant neoplasm of bronchus andlung Health Condition 3: C53- Malignant neoplasm of cervix uteri Health Condition 4: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Adult aged 18 years or more Suspected or confirmed cancer of the head and neck or cervix or lung or breast Presenting to the CMC oncology services for care which includes further diagnostic or staging workup, or definitive local therapy or systemic therapy or structured follow up and outcomes measurement. Provide written informed consent for participation and longitudinal follow up
Exclusion criteria
Exclusion criteria: All patients who are being seen only for an opinion with no further diagnostic tests or structured follow up being planned from CMC. Decline participation or do not wish to be on longitudinal follow up
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Time from oncology presentation to confirmed diagnosis ( T0-T1) 2. Time from diagnosis to first oncology specific treatment (T1-T2)Timepoint: T0- Date of presentation in CMC T1- Date of pathology report T2- Date of initiation of treatment | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient experience and satisfaction. Clinician Acceptability Treatment adherence and abandonment Equity indicators - comparison of T0,T1,T2 across genders, rural or urban setting and across sociao-economic strataTimepoint: These outcomes would be measured at the beginning and end of treatment for patients. Clinical acceptability would be asessed through biannual focus group discussions with relevant clinicans with iterative learning for the program Other equity outcomes would be assessed at the end of the study | — |
Countries
India
Contacts
CMC Vellore